CDK9 and neoplasm: Flavopiridol has been shown to inhibit multiple CDKs [13] and other kinases [14], but the primary mechanism responsible for its observed anti-tumor activity in CLL appeared to be the CDK9-mediated down-regulation of transcription of anti-apoptotic proteins [15].